Corium International, Inc.
(NASDAQ : CORI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.90%194.181.2%$592.16m
GILDGilead Sciences, Inc.
-0.83%69.200.9%$496.51m
BIIBBiogen Inc.
0.72%324.051.3%$476.94m
CELGCelgene Corporation
-0.47%69.651.2%$474.00m
ILMNIllumina, Inc.
0.13%319.933.5%$402.89m
REGNRegeneron Pharmaceuticals, Inc.
1.08%345.332.6%$297.08m
VRTXVertex Pharmaceuticals Incorporated
-0.94%165.111.9%$277.86m
ALXNAlexion Pharmaceuticals, Inc.
-0.89%118.622.0%$201.35m
AAgilent Technologies, Inc.
0.42%64.991.5%$188.27m
EXASExact Sciences Corporation
3.65%71.3825.3%$147.45m
SRPTSarepta Therapeutics, Inc.
0.07%119.0415.4%$145.09m
LGNDLigand Pharmaceuticals Incorporated
1.68%154.4623.3%$145.09m
ECYTEndocyte, Inc.
0.25%23.672.0%$124.13m
INCYIncyte Corporation
2.28%66.512.5%$117.76m
NKTRNektar Therapeutics
0.11%38.235.6%$117.70m

Company Profile

Corium International, Inc. is a commercial stage biopharmaceutical company, which develops, manufactures and commercializes pharmaceutical products. The company development platforms enable transdermal delivery of large molecules or biologics, including vaccines, peptides and proteins, as well as small molecules that are otherwise difficult to deliver in a transdermal dosage form. The firm offers its products under the brands Corplex and MicroCor. Corium International was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA.